PacBio Announces First Quarter 2022 Financial Results
MENLO PARK, Calif., May 04, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2022. First quarter results Revenue of $33.2 million, a 14% increase compared with $29.0 million in the prior year period. Delivered a record 50 Sequel II/IIe systems during the quarter compared to 41... Read more